Kai W. Wucherpfennig

Dana-Farber Cancer Institute ORCID: 0000-0002-1829-302X

3

h-index

3

Publications

7,871

Citations

Publications

3 shown

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

Derin B. Keskin , Annabelle Anandappa , Jing Sun +48 more

2018 Nature 1324 citations

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Livnat Jerby‐Arnon , Parin Shah , Michael S. Cuoco +49 more

2018 Cell 1317 citations

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Peng Jiang , Shengqing Gu , Deng Pan +12 more

2018 Nature Medicine 5230 citations

Frequent Co-Authors

Livnat Jerby‐Arnon

Broad Institute

Parin Shah

Dana-Farber Cancer Institute

Michael S. Cuoco

Broad Institute

Christopher Rodman

Center for Cancer Research

Mei-Ju Su

Dana-Farber Cancer Institute

Johannes C. Melms

Dana-Farber Cancer Institute

Researcher Info

h-index: 3
Publications: 3
Citations: 7,871
Institution: Dana-Farber Cancer Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-1829-302X

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.